Physician profile
Christopher Luke Wilcox
NPI 1497963425
$14,121.31
in general payments reported to CMS, 2019-2025
23 companies · $676 in 2025
The $676 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,730 · 2020: $1,763 · 2021: $3,622 · 2022: $2,930 · 2023: $776 · 2024: $625 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,076.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,640.69 | 2019-2025 | |
| Medwest Associates | $2,892.64 | 2019-2022 | |
| Encore Medical, LP | $758.39 | 2022 | |
| Smith+Nephew, INC. | $656.83 | 2019-2023 | Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium, Firstpass |
| Stryker Corporation | $457.38 | 2019-2024 | Blueprint Patient Specific Instrumentation, Mako, Aequalis Flex Revive |
| Solventum Corporation | $244.05 | 2024-2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Vericel Corporation | $187.03 | 2021-2025 | Maci |
| Djo, LLC | $150.88 | 2019 | |
| Orthofix Medical, INC. | $139.23 | 2023-2025 | Physio-Stim |
| Davol INC. | $137.33 | 2023 | Channel Drain |
| Zimmer Biomet Holdings, INC. | $123.92 | 2024-2025 | Juggerknotless Soft Anchor, Tapestry, Comprehensive Shoulder System |
| Heron Therapeutics, INC. | $117.18 | 2023 | Aponvie |
| Pacira Pharmaceuticals Incorporated | $109.08 | 2023-2024 | Iovera |
| Next Science LLC | $104.69 | 2024 | Xperience, Blastx, Surgx |
| Boston Scientific Corporation | $62.86 | 2025 | General - Pain Management |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $58.25 | 2023 | Tenoglide |
| Bioventus LLC | $58.21 | 2022-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Sanara Medtech INC. | $50.30 | 2022-2025 | Celleraterx |
| Kowa Pharmaceuticals America, INC. | $42.52 | 2022-2023 | Seglentis |
| Ferring Pharmaceuticals INC. | $38.32 | 2024-2025 | Euflexxa |
| Lightbody Medical Technologies INC | $36.21 | 2024 | |
| Embody, INC. | $34.23 | 2022 | |
| Abbott Laboratories | $21.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wilcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.